Pattipati Meghana, Gudavalli Goutham
Internal Medicine, The Brooklyn Hospital Center, Brooklyn, USA.
Critical Care Medicine, Rapides Regional Medical Center, Alexandria, USA.
Cureus. 2022 Feb 9;14(2):e22044. doi: 10.7759/cureus.22044. eCollection 2022 Feb.
Background Cushing's syndrome is a metabolic disorder related to excess cortisol production. Patients with Cushing's syndrome are at risk for the development of other comorbid medical conditions such as hypertension, diabetes, obesity, and obstructive sleep apnea. Obstructive sleep apnea has been well associated with endocrine disorders such as acromegaly and hypothyroidism. However, its causal association with Cushing's syndrome is still unclear. We utilized a national database to study the prevalence of sleep apnea in Cushing's syndrome. Hypothesis We hypothesized that patients with Cushing's syndrome might have an increased prevalence of sleep apnea. Methods Patients aged above 18 years from the NIS database between 2017 and 2018 with a diagnosis of Cushing's syndrome and sleep apnea were extracted using the 10th revision of the International Classification of Diseases (ICD-10) codes, with code E24 representing Cushing's syndrome and G47.3 representing sleep apnea. The prevalence of sleep apnea and other comorbid medical conditions were identified using the ICD-10 codes. Logistic regression analysis was performed to examine the association between Cushing's syndrome and sleep apnea. Results Cushing's syndrome was prevalent in 0.037% (2,248 of 6,023,852) of all inpatient hospitalizations. Patients with Cushing's syndrome were slightly younger (mean age: 54 ± 16 versus 58 ± 20) and more likely to be females (76%, 1,715 out of 2,248) and had higher rates of sleep apnea (21.9% versus 8.7%, p < 0.000) and obstructive sleep apnea (OSA) (18.6% versus 7.2%, p < 0.000) when compared to the general population. Cushing's syndrome is independently associated with sleep apnea, with an unadjusted odds ratio (OR) of 2.94 (p < 0.01) and an adjusted odds ratio (aOR) of 1.79 after adjusting for demographics and other risk factors for sleep apnea and comorbid medical conditions (p < 0.01). Conclusions Cushing's syndrome is associated with increased prevalence of sleep apnea and independent predictor of sleep apnea. Further prospective studies are recommended to validate the causal association. The high prevalence and coexistence of both these disorders validate screening for sleep apnea as part of routine workup in patients with Cushing's syndrome and vice versa.
库欣综合征是一种与皮质醇分泌过多相关的代谢紊乱疾病。库欣综合征患者有发生其他合并症的风险,如高血压、糖尿病、肥胖症和阻塞性睡眠呼吸暂停。阻塞性睡眠呼吸暂停与肢端肥大症和甲状腺功能减退等内分泌疾病密切相关。然而,其与库欣综合征的因果关系仍不明确。我们利用一个全国性数据库研究库欣综合征患者睡眠呼吸暂停的患病率。
我们假设库欣综合征患者睡眠呼吸暂停的患病率可能会增加。
使用国际疾病分类第10版(ICD - 10)编码,从2017年至2018年NIS数据库中提取年龄在18岁以上、诊断为库欣综合征且患有睡眠呼吸暂停的患者,其中E24编码代表库欣综合征,G47.3编码代表睡眠呼吸暂停。使用ICD - 10编码确定睡眠呼吸暂停和其他合并症的患病率。进行逻辑回归分析以检验库欣综合征与睡眠呼吸暂停之间的关联。
在所有住院患者中,库欣综合征的患病率为0.037%(6,023,852例中有2,248例)。与普通人群相比,库欣综合征患者年龄稍小(平均年龄:54±16岁对58±20岁),女性比例更高(76%,2,248例中有1,715例),睡眠呼吸暂停发生率更高(21.9%对8.7%,p<0.000),阻塞性睡眠呼吸暂停(OSA)发生率更高(18.6%对7.2%,p<0.000)。库欣综合征与睡眠呼吸暂停独立相关,未调整的优势比(OR)为2.94(p<0.01),在调整人口统计学和其他睡眠呼吸暂停及合并症的危险因素后,调整后的优势比(aOR)为1.79(p<0.01)。
库欣综合征与睡眠呼吸暂停患病率增加相关,是睡眠呼吸暂停的独立预测因素。建议进一步进行前瞻性研究以验证因果关系。这两种疾病的高患病率和共存情况证实了对库欣综合征患者进行睡眠呼吸暂停筛查作为常规检查的一部分是合理的,反之亦然。